Ann: New Clinical Practice Guidance Recommends Use of BIS, page-34

I see the problem with your definition of Best Practice in this instance is that this article only recommends BIS as an option on an interim basis until more clinical trial findings come to light which will provide a more comprehensive guide.

Hardly a glowing recommendation for SOZO to become best practice, let alone standard of care. All of which goes back to my point of how this article does nothing to assist IPD in establishing a monopoly in the BCRAL field, therefore I fail how to see it is good news. The only benefit to this review that I see comes from the old adage that no publicity is bad publicity.

" Bioimpedance spectroscopy (BIS) was recommended as an option for early lymphoedema detection before more prospective studies are performed
to suggest the preferred method of detection."